Literature DB >> 22130762

Tuberculosis and HIV co-infection: do we have a surveillance system in Europe?

E Pontali, M B Pasticci, A Matteelli, F Baldelli, G B Migliori.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22130762     DOI： 10.1183/09031936.00143111

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  5 in total

1.  Multidrug-resistant tuberculosis today.

Authors:  A Matteelli; R Centis; L D'Ambrosio; G B Migliori
Journal:  Bull World Health Organ       Date:  2012-02-01       Impact factor: 9.408

2.  HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data.

Authors:  Lena Fiebig; Christian Kollan; Barbara Hauer; Barbara Gunsenheimer-Bartmeyer; Matthias An der Heiden; Osamah Hamouda; Walter Haas
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

3.  European union standards for tuberculosis care.

Authors:  G B Migliori; J P Zellweger; I Abubakar; E Ibraim; J A Caminero; G De Vries; L D'Ambrosio; R Centis; G Sotgiu; O Menegale; K Kliiman; T Aksamit; D M Cirillo; M Danilovits; M Dara; K Dheda; A T Dinh-Xuan; H Kluge; C Lange; V Leimane; R Loddenkemper; L P Nicod; M C Raviglione; A Spanevello; V Ø Thomsen; M Villar; M Wanlin; J A Wedzicha; A Zumla; F Blasi; E Huitric; A Sandgren; D Manissero
Journal:  Eur Respir J       Date:  2012-04       Impact factor: 16.671

Review 4.  Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement.

Authors:  Masoud Dara; Pierpaolo de Colombani; Roumyana Petrova-Benedict; Rosella Centis; Jean-Pierre Zellweger; Andreas Sandgren; Einar Heldal; Giovanni Sotgiu; Niesje Jansen; Rankica Bahtijarevic; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2012-05-31       Impact factor: 16.671

5.  Tuberculosis incidence in HIV/AIDS patients in Israel, 1983-2010.

Authors:  Zohar Mor; Moshe Lidji; Noa Cedar; Itamar Grotto; Daniel Chemtob
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.